Original language | English (US) |
---|---|
Pages (from-to) | 273 |
Number of pages | 1 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 148 |
Issue number | 1 |
DOIs | |
State | Published - Jul 2021 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Reply. / Keet, Corinne; Shreffler, Wayne; Wood, Robert et al.
In: Journal of Allergy and Clinical Immunology, Vol. 148, No. 1, 07.2021, p. 273.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Reply
AU - Keet, Corinne
AU - Shreffler, Wayne
AU - Wood, Robert
AU - Togias, Alkis
AU - Pistiner, Michael
N1 - Funding Information: Disclosure of potential conflict of interest: C. Keet receives royalties from Up to Date. W. Shreffler has served on the Scientific Advisory Board of Aimmune Therapeutics, and as an advisor to Food Allergy Research & Education (FARE), Buhlmann Laboratories AG, and Sanofi Pasteur. R. Wood receives research support from FARE, Aimmune, DBV, Astellas, Regeneron, Sanofi, and HAL-Allergy, and royalties from Up to Date. A. Togias reports no relevant conflicts of interest. M. Pistiner has served as a consultant for Asthma and Allergy Foundation of America, kaléo, and DBV Technologies; received funding from kaléo, DBV Technologies, and the National Peanut Board; and is cofounder of AllergyHome and Allergy Certified Training. Funding Information: This study was funded by the National Institutes of Health (NIH)/ National Institute of Allergy and Infectious Diseases (grant no. 1U01AI125290 ). This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by the National Center for Advancing Translational Sciences (NCATS) (grant no. UL1 TR003098 ), a component of the NIH , and NIH Roadmap for Medical Research . Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH. The project described was supported by grant number 1UL1TR002541-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the NCATS, or the NIH. Funding Information: This study was funded by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (grant no. 1U01AI125290). This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by the National Center for Advancing Translational Sciences (NCATS) (grant no. UL1 TR003098), a component of the NIH, and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH. The project described was supported by grant number 1UL1TR002541-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the NCATS, or the NIH. Disclosure of potential conflict of interest: C. Keet receives royalties from Up to Date. W. Shreffler has served on the Scientific Advisory Board of Aimmune Therapeutics, and as an advisor to Food Allergy Research & Education (FARE), Buhlmann Laboratories AG, and Sanofi Pasteur. R. Wood receives research support from FARE, Aimmune, DBV, Astellas, Regeneron, Sanofi, and HAL-Allergy, and royalties from Up to Date. A. Togias reports no relevant conflicts of interest. M. Pistiner has served as a consultant for Asthma and Allergy Foundation of America, kal?o, and DBV Technologies; received funding from kal?o, DBV Technologies, and the National Peanut Board; and is cofounder of AllergyHome and Allergy Certified Training.
PY - 2021/7
Y1 - 2021/7
UR - http://www.scopus.com/inward/record.url?scp=85106983547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106983547&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2021.03.013
DO - 10.1016/j.jaci.2021.03.013
M3 - Letter
C2 - 33926728
AN - SCOPUS:85106983547
VL - 148
SP - 273
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 1
ER -